Cargando…

New prognostic score based on galectin-3 has similar performance to model for end-stage liver disease and sodium score in patients with stable decompensated cirrhosis

BACKGROUND: Galectin-3 (gal-3) has been proposed as a marker of established renal impairment, with predictive value in stable decompensated cirrhosis. METHODS: 150 stable decompensated patients were assessed in 2 transplant centers. Patients’ renal function was assessed using (51)Chromium-EDTA (“tru...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oikonomou, Theodora, Orfanidou, Afroditi, Goulis, Ioannis, Ntogramatzi, Fani, Athanasiadou, Zoi, Papatheodoridis, George V., Cholongitas, Evangelos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hellenic Society of Gastroenterology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375656/ https://www.ncbi.nlm.nih.gov/pubmed/34475745 http://dx.doi.org/10.20524/aog.2021.0633

Ejemplares similares

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

The significance of C-reactive protein to albumin ratio in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2020)

Aspartate aminotransferase-to-platelet ratio index can predict the outcome in patients with stable decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2023)

High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2017)

The impact of newer nucleos(t)ide analogues on patients with hepatitis B decompensated cirrhosis
por: Cholongitas, Evangelos, et al.
Publicado: (2015)

Hepatopulmonary syndrome is associated with the presence of hepatocellular carcinoma in patients with decompensated cirrhosis
por: Soulaidopoulos, Stergios, et al.
Publicado: (2017)

Management of Hepatocellular Carcinoma in Decompensated Cirrhotic Patients: A Comprehensive Overview
por: Tampaki, Maria, et al.
Publicado: (2023)

Type 1 autoimmune hepatitis presenting with severe autoimmune neutropenia
por: Doumtsis, Petros, et al.
Publicado: (2018)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Clinical Characteristics, Etiology, and Prognostic Scores in Patients with Acute Decompensated Liver Cirrhosis
por: Al Kaabi, Hoor, et al.
Publicado: (2023)

The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score
por: Theocharidou, Eleni, et al.
Publicado: (2014)

Establishment of prognostic scoring models for different etiologies of acute decompensation in hospitalized patients with cirrhosis
por: Cai, Qun, et al.
Publicado: (2019)

Predictive scoring systems for in-hospital mortality due to acutely decompensated liver cirrhosis in Indonesia
por: Nababan, Saut Horas H., et al.
Publicado: (2021)

Erratum: The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score
por: Theocharidou, Eleni, et al.
Publicado: (2017)

Corrigendum: The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score
por: Theocharidou, Eleni, et al.
Publicado: (2014)

Scoring systems for prediction of mortality in decompensated liver cirrhosis: A meta-analysis of test accuracy
por: Wu, Shi-Lan, et al.
Publicado: (2018)

Risk Stratification Score to Predict Readmission of Patients With Acute Decompensated Cirrhosis Within 90 Days
por: Xu, Xiaomei, et al.
Publicado: (2021)

Evaluation of the Prognostic Value of Existing Scoring Systems for Nosocomial Infection in Patients with Decompensated Liver Cirrhosis
por: Zhao, Xu, et al.
Publicado: (2023)

Hepatitis B virus reactivation in HBsAg-negative, anti-HBc-positive patients receiving immunosuppressive therapy: a systematic review
por: Cholongitas, Evangelos, et al.
Publicado: (2018)

Sofosbuvir: a novel oral agent for chronic hepatitis C
por: Cholongitas, Evangelos, et al.
Publicado: (2014)

Fungal Infection in Acutely Decompensated Cirrhosis Patients: Value of Model for End-Stage Liver Disease Score
por: Habib, Shahid, et al.
Publicado: (2020)

Evaluation of five lymphocyte-based scores for prediction of mortality in hepatitis B virus-associated decompensated cirrhosis
por: Mao, Ting, et al.
Publicado: (2023)

Pulmonary manifestations of chronic liver disease: a comprehensive review
por: Soulaidopoulos, Stergios, et al.
Publicado: (2020)

The impact and role of hepatic hydrothorax in the prognosis of patients with decompensated cirrhosis: A retrospective propensity score-matched study
por: Ma, Bo, et al.
Publicado: (2022)

A modified Child-Turcotte-Pugh score based on plasma ammonia predicts survival for patients with decompensated cirrhosis
por: Wang, X, et al.
Publicado: (2023)

Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation
por: Cholongitas, Evangelos, et al.
Publicado: (2017)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

The Lyon Consensus Criteria for GERD Diagnosis in a Greek Population: The Clinical Impact and Changes in GERD Diagnosis in a Real-World, Retrospective Study
por: Voulgaris, Theodoros, et al.
Publicado: (2022)

Efficacy of citalopram or amitriptyline versus no treatment in patients with functional chest pain
por: Voulgaris, Theodoros, et al.
Publicado: (2023)

Baseline MELD Score Predicts Hepatic Decompensation during Antiviral Therapy in Patients with Chronic Hepatitis C and Advanced Cirrhosis
por: Dultz, Georg, et al.
Publicado: (2013)

Predicting 1-year mortality among patients with decompensated cirrhosis: results of a multicentre evaluation of the Bristol Prognostic Score
por: Bowers, Sarah Pauline, et al.
Publicado: (2022)

Patient‐oriented medication education intervention has long‐term benefits for people with decompensated cirrhosis
por: Hayward, Kelly L., et al.
Publicado: (2022)

Pulmonary function testing in patients with liver cirrhosis (Review)
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2023)

Serum Ferritin Levels: A Potential Biomarker to Represent Child-Turcotte-Pugh Score among Decompensated Liver Cirrhosis Patients
por: Sungkar, Taufik, et al.
Publicado: (2019)

CLIF-SOFA and CLIF-C scores for the prognostication of acute-on-chronic liver failure and acute decompensation of cirrhosis: A systematic review
por: Rashed, Ebrahim, et al.
Publicado: (2022)

Model for End Stage Liver Disease (MELD) Score: A Tool for Prognosis and Prediction of Mortality in Patients With Decompensated Liver Cirrhosis
por: Emenena, Isioma, et al.
Publicado: (2023)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_nhvui2q9n9purdietskg133hrl